Bioject Medical Technologies Inc. President and CEO to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free injection therapy systems, today announced that Mr. Ralph Makar, President and CEO, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, being held November 5-7, 2007. The presentation will be held Wednesday, November 7, 2007 at 11:30 am (ET) at the New York Palace Hotel in New York City.

MORE ON THIS TOPIC